If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?

Core Insights - Pfizer Inc. is a global biopharmaceutical company involved in the discovery, development, manufacturing, and marketing of medicines, vaccines, and healthcare products [1] Financial Performance - Pfizer is set to report its Q4 2025 earnings on February 3, with Wall Street analysts expecting an EPS of $0.61, a decrease from $0.63 in the prior-year period [2] - Quarterly revenue is anticipated to reach $17.67 billion, down from $17.76 billion a year earlier [2] - For Q3 2025, Pfizer reported adjusted EPS of $0.87, exceeding the consensus estimate of $0.63, and revenues of $16.65 billion, slightly above the consensus of $16.59 billion [7] - The company raised its full-year 2025 adjusted EPS guidance to a range of $3 to $3.15, compared to the consensus estimate of $3.04 [7] - Pfizer reaffirmed its full-year revenue guidance of $61 billion to $64 billion, compared to the consensus of $62.88 billion [7] Historical Stock Performance - Ten years ago, Pfizer's stock traded at approximately $31.11 per share, and an investment of $10,000 would have allowed the purchase of roughly 321 shares [3] - Currently, shares trade at $25.71, indicating a decline in investment value to $8,264 due to stock price depreciation [3] - Over the past decade, Pfizer has paid about $15.70 in dividends per share, totaling $5,047 from dividends alone [4] - The total value of a $10,000 investment in Pfizer stock 10 years ago would be $13,311, resulting in a total return of 33.11%, significantly lower than the S&P 500 total return of 287.90% for the same period [5] Analyst Ratings - Pfizer has a consensus rating of "Neutral" with a price target of $33.35, suggesting more than 29% potential upside from the current stock price based on the ratings of 24 analysts [6]